Act Two Investors LLC Astrazeneca PLC Transaction History
Act Two Investors LLC
- $522 Million
- Q3 2024
A detailed history of Act Two Investors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Act Two Investors LLC holds 320,839 shares of AZN stock, worth $21.1 Million. This represents 4.79% of its overall portfolio holdings.
Number of Shares
320,839
Previous 319,957
0.28%
Holding current value
$21.1 Million
Previous $25 Million
0.18%
% of portfolio
4.79%
Previous 5.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...